Search Results - Lauri E. Markowitz

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United States by Elissa Meites, Timothy J. Wilkin, Lauri E. Markowitz

    Published in Human Vaccines & Immunotherapeutics (2022-01-01)
    Get full text
    Article


  2. 2

    Cost-effectiveness of Human Papillomavirus Vaccination in the United States by Harrell W. Chesson, Donatus U. Ekwueme, Mona Saraiya, Lauri E. Markowitz

    Published in Emerging Infectious Diseases (2008-02-01)
    Get full text
    Article


  3. 3

    Updated medical care cost estimates for HPV-associated cancers: implications for cost-effectiveness analyses of HPV vaccination in the United States by Harrell W. Chesson, Elissa Meites, Donatus U. Ekwueme, Mona Saraiya, Lauri E. Markowitz

    Published in Human Vaccines & Immunotherapeutics (2019-08-01)
    Get full text
    Article


  4. 4

    Delayed dosing intervals for quadrivalent human papillomavirus vaccine do not reduce antibody avidity by Allison M. Brady, Emmanuel B. Walter, Lauri E. Markowitz, Elizabeth R. Unger, Gitika Panicker

    Published in Human Vaccines & Immunotherapeutics (2020-08-01)
    Get full text
    Article


  5. 5

    Monitoring the impact of HPV vaccine in males—Considerations and challenges by Julia M.L. Brotherton, Anna R. Giuliano, Lauri E. Markowitz, Eileen F. Dunne, Gina S. Ogilvie

    Published in Papillomavirus Research (2016-12-01)
    Get full text
    Article


  6. 6

    Human papillomavirus vaccination at age 9 or 10 years to increase coverage – a narrative review of the literature, United States 2014–2024 by Sarah K. Brewer, Ruth Stefanos, Neil C. Murthy, Amimah F. Asif, Shannon Stokley, Lauri E. Markowitz

    Published in Human Vaccines & Immunotherapeutics (2025-12-01)
    Get full text
    Article


  7. 7

    Is vaccine type seropositivity a marker for human papillomavirus vaccination? National Health and Nutrition Examination Survey, 2003–2010 by Emiko Y. Petrosky, Susan Hariri, Lauri E. Markowitz, Gitika Panicker, Elizabeth R. Unger, Eileen F. Dunne

    Get full text
    Article


  8. 8

    CDC Activities for Improving Implementation of Human Papillomavirus Vaccination, Cervical Cancer Screening, and Surveillance Worldwide by Virginia Senkomago, Denise Duran, Anagha Loharikar, Terri B. Hyde, Lauri E. Markowitz, Elizabeth R. Unger, Mona Saraiya

    Published in Emerging Infectious Diseases (2017-12-01)
    Get full text
    Article


  9. 9

    High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003–2006 and 2015–2018 by Ruth Stefanos, Rayleen M. Lewis, Troy D. Querec, Julia W. Gargano, Elizabeth R. Unger, Lauri E. Markowitz

    Published in Human Vaccines & Immunotherapeutics (2024-12-01)
    Get full text
    Article


  10. 10

    Trends in human papillomavirus (HPV) vaccination initiation among adolescents aged 13–17 by metropolitan statistical area (MSA) status, National Immunization Survey – Teen, 2013 –... by Tanja Y. Walker, Laurie D. Elam-Evans, Charnetta L. Williams, Benjamin Fredua, David Yankey, Lauri E. Markowitz, Shannon Stokley

    Published in Human Vaccines & Immunotherapeutics (2020-03-01)
    Get full text
    Article


  11. 11

    Human papillomavirus vaccination coverage among young, gay, bisexual, and other men who have sex with men and transgender women — 3 U.S. cities, 2016–2018 by Raiza Amiling, Rachel L. Winer, Michael E. Newcomb, Pamina M. Gorbach, John Lin, Richard A. Crosby, Brian Mustanski, Lauri E. Markowitz, Elissa Meites

    Published in Human Vaccines & Immunotherapeutics (2021-12-01)
    Get full text
    Article


  12. 12

    Immunogenicity and duration of antibodies after vaccination with a two-dose series of the nine-valent human papillomavirus vaccine among Alaska Native children: a prospective cohor... by Jonathan Steinberg, Gitika Panicker, Elizabeth R. Unger, Ian Blake, Rayleen M. Lewis, Jesse Geis, Dana Bruden, Marc Fischer, Lauri E. Markowitz, Michael G. Bruce

    Published in BMC Infectious Diseases (2025-04-01)
    Get full text
    Article


  13. 13

    HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006. by Susan Hariri, Martin Steinau, Allen Rinas, Julia W Gargano, Christina Ludema, Elizabeth R Unger, Alicia L Carter, Kathy L Grant, Melanie Bamberg, James E McDermott, Lauri E Markowitz, Noel T Brewer, Jennifer S Smith

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  14. 14

    Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008–2012 by Susan Hariri, Lauri E. Markowitz, Nancy M. Bennett, Linda Niccolai, Sean D. Schafer, Karen C. Bloch, Ina U. Park, Mary W. Scahill, Pamela Julian, Nasreen Abdullah, Diane Levine, Erin Whitney, Elizabeth R. Unger, Martin Steinau, Heidi M. Bauer, James I. Meek, James L. Hadler, Lynn Sosa, Suzanne E. Powell, Michelle L. Johnson, HPV-IMPACT Working Group

    Published in Emerging Infectious Diseases (2015-09-01)
    Get full text
    Article


Search Tools: